Form 4: USPH COO Sells Shares Under Pre-Arranged Plan

U.S. Physical Therapy's COO, Graham D. Reeve, sold 1,792 shares of common stock for $86.57 per share, executed under a Rule 10b5-1 plan.

Summary

• Graham D. Reeve, Chief Operating Officer of U.S. Physical Therapy Inc. (USPH), sold 1,792 shares of common stock.
• The sale occurred on August 11, 2025, at a price of $86.57 per share.
• Following the transaction, Mr. Reeve directly owns 22,246 shares and indirectly owns 1,808 shares through the Reeve Trust, totaling 24,054 shares.
• The transaction was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled sale.
• Mr. Reeve's holdings include 17,244 restricted shares from the Company's Amended and Restated 2003 Stock Incentive Plan, with restrictions lapsing on various dates through March 6, 2029, contingent on his continued employment.

Sentiment

Score: 5

Explanation: A neutral score. This is a routine insider sale under a pre-arranged plan, which is common for executives and typically does not signal strong positive or negative sentiment about the company's immediate prospects. It's a personal financial management event.

Positives

• The sale was conducted under a Rule 10b5-1 plan, which suggests a pre-planned transaction rather than a reaction to immediate company news, potentially reducing concerns about insider sentiment.

Negatives

• An insider sale, even if pre-planned, reduces the insider's direct equity stake in the company.

Future Outlook

The filing indicates future vesting dates for restricted stock through March 2029, contingent on the COO's continued employment, suggesting a long-term retention strategy for key management.

Industry Context

This Form 4 filing reflects an individual insider transaction within the healthcare services sector, specifically physical therapy. Such routine insider sales, especially those under Rule 10b5-1 plans, are common and generally do not indicate a shift in broader industry trends or competitive landscape.

Comparison to Industry Standards

• Insider transactions, particularly sales, are common across all industries.
• A sale under a Rule 10b5-1 plan is considered standard practice for executives to diversify holdings or manage liquidity without being accused of trading on material non-public information.
• There are no specific comparable companies or projects mentioned in this filing to assess against industry benchmarks beyond the general practice of insider trading disclosures.

Related Party Transactions

• Indirect beneficial ownership of 1,808 shares through Reeve Trust.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but mitigated by the Rule 10b5-1 plan. The continued holding of a significant number of shares, including restricted stock, indicates ongoing alignment with shareholder interests.

Next Steps

• Continued vesting of 17,244 restricted shares on various dates through March 6, 2029, contingent on the COO's employment.

Key Dates

Recommendation

This Form 4 filing reports a routine insider sale executed under a Rule 10b5-1 plan. Such pre-scheduled transactions are common for executives managing personal finances and typically do not reflect new material information about the company's performance or outlook. The COO retains a substantial number of shares, including significant restricted stock holdings with future vesting dates, indicating continued alignment with the company's long-term success. Therefore, this specific filing does not provide a basis for a change in investment recommendation; a 'hold' stance is appropriate as the transaction is an expected personal financial event rather than a signal of corporate distress or exceptional performance.

Keywords

USPH, U.S. Physical Therapy, Graham D. Reeve, Insider Sale, Form 4, Stock Transaction, COO, Rule 10b5-1, Restricted Stock